What is he best known for?
The fields of study he is best known for:
- Bacteria
- Gene
- Antibiotics
David C. Hooper mainly investigates Microbiology, DNA gyrase, Antibacterial agent, Plasmid and Drug resistance.
His Microbiology research integrates issues from Efflux and Klebsiella pneumoniae, Enterobacteriaceae, Escherichia coli.
His DNA gyrase study combines topics from a wide range of disciplines, such as Mutation, DNA and Quinolone.
David C. Hooper combines subjects such as Ciprofloxacin, Vancomycin, Molecular biology and Mechanism of action with his study of Antibacterial agent.
His Plasmid study is concerned with the larger field of Genetics.
His Drug resistance research is multidisciplinary, incorporating elements of Bacteremia, Pharmacotherapy, Intensive care medicine and Activity spectrum.
His most cited work include:
- Hospital-Acquired Infections Due to Gram-Negative Bacteria (889 citations)
- Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy (723 citations)
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase (709 citations)
What are the main themes of his work throughout his whole career to date?
David C. Hooper focuses on Microbiology, DNA gyrase, Antibacterial agent, Escherichia coli and Quinolone.
His studies deal with areas such as Plasmid, Efflux and Staphylococcus aureus as well as Microbiology.
The Staphylococcus aureus study which covers Mutant that intersects with Molecular biology and Transcription.
His DNA gyrase research incorporates themes from Topoisomerase, DNA and Drug resistance.
In most of his Antibacterial agent studies, his work intersects topics such as Klebsiella pneumoniae.
In his work, Internal medicine is strongly intertwined with Antibiotics, which is a subfield of Antimicrobial.
He most often published in these fields:
- Microbiology (41.58%)
- DNA gyrase (21.99%)
- Antibacterial agent (18.56%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (13.75%)
- Microbiology (41.58%)
- Antibiotics (14.43%)
In recent papers he was focusing on the following fields of study:
David C. Hooper spends much of his time researching Internal medicine, Microbiology, Antibiotics, Mutant and Plasmid.
As part of his studies on Microbiology, David C. Hooper frequently links adjacent subjects like In vivo.
His Antibiotics research includes elements of Sepsis, Retrospective cohort study, Urinary system, Algorithm and Drug resistance.
David C. Hooper has included themes like Efflux, Cell biology, Repressor and Staphylococcus aureus in his Mutant study.
David C. Hooper has researched Plasmid in several fields, including Escherichia coli, DNA gyrase, Vibrio vulnificus and DnaA.
His Escherichia coli research focuses on Ciprofloxacin and how it relates to Transcription and Quinolone.
Between 2017 and 2021, his most popular works were:
- Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. (92 citations)
- A Generalizable, Data-Driven Approach to Predict Daily Risk of Clostridium difficile Infection at Two Large Academic Health Centers (56 citations)
- Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. (39 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Gene
- Antibiotics
His scientific interests lie mostly in Antibiotics, Internal medicine, Incidence, Microbiology and Antibiotic resistance.
His work carried out in the field of Antibiotics brings together such families of science as Drug resistance and Sepsis.
His work in Drug resistance tackles topics such as Urinary system which are related to areas like Confidence interval.
His research investigates the connection between Incidence and topics such as Delafloxacin that intersect with problems in Aztreonam, Vancomycin, Tolerability, Safety profile and Methicillin-resistant Staphylococcus aureus.
His study in the fields of Ciprofloxacin under the domain of Microbiology overlaps with other disciplines such as Strain.
His studies in Antibiotic resistance integrate themes in fields like Drug development and Carbapenem resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
